| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8238035 | International Journal of Radiation Oncology*Biology*Physics | 2008 | 7 Pages |
Abstract
Overall survival seems to be comparable in both groups, although longer follow-up and a larger group of patients are needed to corroborate these results. Lower dosing of TMZ also is associated with a more beneficial toxicity profile.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Stephanie E. M.D., Johanna Wagner, Marc M.D., Thomas M.D., Lutz Ph.D., Renate Rausch, Florian Wagner, Angelika M.D., Jürgen M.D., Ph.D., Daniela M.D.,